Dawei Ding
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Silk-based biomaterials and applications
- Supramolecular Self-Assembly in Materials
- Pharmaceutical Science top 5%
Papers in
-
- Nanoplatforms for cancer theranostics 11
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Mengying He (6 shared papers)Ali Miserez (4 shared papers)Huabing Chen (4 shared papers)Tao Xu (7 shared papers)Shahrouz Amini (3 shared papers)Shawn Hoon (3 shared papers)Paul A. Guerette (3 shared papers)Tao Yang (2 shared papers)
In The Last Decade
Dawei Ding
29 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Biomaterials 387
- Pharmaceutical Science 80
- Biomedical Engineering 444
- Immunology 207
- Surfaces, Coatings and Films 57
Countries citing papers authored by Dawei Ding
This map shows the geographic impact of Dawei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Ding more than expected).
Fields of papers citing papers by Dawei Ding
This network shows the impact of papers produced by Dawei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Ding. The network helps show where Dawei Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 155 | |
| 2 | 2020 | 127 | |
| 3 | Reactive oxygen species-powered cancer immunotherapy: Current status and challenges Hit paper breakdown → | 2023 | 105 |
| 4 | 2021 | 105 | |
| 5 | 2014 | 84 | |
| 6 | 2021 | 65 | |
| 7 | 2013 | 59 | |
| 8 | 2014 | 47 | |
| 9 | 2023 | 42 | |
| 10 | 2017 | 41 | |
| 11 | 2017 | 39 | |
| 12 | 2024 | 37 | |
| 13 | 2023 | 30 | |
| 14 | 2022 | 30 | |
| 15 | 2018 | 21 | |
| 16 | 2020 | 19 | |
| 17 | 2023 | 19 | |
| 18 | 2022 | 15 | |
| 19 | 2023 | 10 | |
| 20 | 2022 | 10 |
About Dawei Ding
Dawei Ding is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Pulmonary and Respiratory Medicine and Immunology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Photodynamic Therapy Research Studies (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Advanced Drug Delivery Systems (4 papers), Immune cells in cancer (4 papers), RNA Interference and Gene Delivery (3 papers), Advancements in Transdermal Drug Delivery (3 papers) and Silk-based biomaterials and applications (3 papers). The work is most often cited by research in Biomaterials (387 citations), Pharmaceutical Science (80 citations), Biomedical Engineering (444 citations), Immunology (207 citations) and Surfaces, Coatings and Films (57 citations). Dawei Ding has collaborated with scholars based in China, Ireland and Singapore. Frequent co-authors include Mengying He, Ali Miserez, Huabing Chen, Tao Xu, Shahrouz Amini, Shawn Hoon, Paul A. Guerette, Tao Yang, Admir Mašić and Zhiyuan Zhong. Their work appears in journals such as Journal of Controlled Release, Asian Journal of Pharmaceutical Sciences, Advanced Materials, Molecular Cancer Therapeutics and Journal of Materials Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.